Aktuellt
SENASTE
Bactiguard’s Q3 sales of SEK 45.2m were 5% above expectations. Q3 adj. EBITDA amounted to SEK 1.2m (SEB at SEK 2.4m). Bactiguard comments that BD sales are now back at normal levels, however, it also comments that sales of BIP products are still affected by C-19, although they have recovered during the year. Future development remains difficult to assess. After a first glance of the report, we expect only minor revisions to estimates post Q3 (prel.).
LÄS MER
